1. Home
  2. Topics
  3. RaQualia Announced That RaQualia President Was Selected as One of the Three Finalists in the Accelerating Category for 2011 EOY Japan

Topics

RaQualia announced that RaQualia President was selected as one of the three finalists
in the Accelerating Category for 2011 EOY Japan

 
RaQualia Pharma Inc. (RaQualia) announced today that Ernst & Young Japan selected RaQualia President & CEO Atsushi Nagahisa as one of the three finalists in the Accelerating Category for JFY 2011 Entrepreneur of the Year (EOY) Japan Award.
 
For further information, please refer to the Ernst & Young Japan website at the following address: http://www.ey.com/JP/ja/Home/Home
 
####

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Facilities
Access
Press Release
Research & Development
Collaboration
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Anidulafungin
Ziprasidone
Dalbavancin
EP4 Antagonist
Cyclooxygenase-2 (COX-2) Inhibitor
Ghrelin Receptor Agonist
5-HT4 Partial Agonist
Acid Pump Antagonist
5-HT2B Antagonist
CB2 Agonist
Motilin Receptor Agonist
Licensing
Shareholder and Investor Information
To our Shareholders and Investors
Vision, Management Principle and Culture
Corporate Governance
Stock Quotes
Outline of Securities Matters
IR Library
IR Calendar
Disclaimer
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Corporate Introduction Video
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release
Topics